Craig Coleman, InCHIP Affiliate, Co-Director of UConn Hopes within InCHIP and Professor of Pharmacy Practice, discussed with MD Magazine a study looking at some of the more popular anticoagulants on the market and how effective they are when patients follow the recommended dosage, and also what it can mean when the prescription is not followed. He recently presented the study at the American Heart Association’s annual scientific sessions in Orlando.

Recent research by InCHIP PI and Professor of Human Development and Family Studies Kim Gans was featured in a Connecticut Health I-Team article, which appeared in the Hartford Courant and CT Post as well. The research examined feeding and physical activity practices in home-based day care settings through focus groups with Hispanic female providers. It was one of six InCHIP studies published in a special section of the October issue of Childhood Obesity.

The Hartford Courant recently featured Biorasis, a UConn biomedical start-up company, and its product, “Glucowizzard,” a fully implantable sensor smaller than a grain of rice, which continuously monitors glucose levels and relays real-time data to wristwatch-like receivers and smartphones. InCHIP PI and Board of Trustees Distinguished Professor of Pharmaceutical Sciences Diane Burgess and her collaborators, Chemistry Professor Fotios Papadimitrakopoulos and InCHIP Affiliate and Professor of Electrical and Computer Engineering Faquir Jain together developed Glucowizzard. It is one of the first two biosensor-based e-health technologies BioCHIP will pair with behavioral health interventions to prevent and address obesity and related conditions.